Drug manufacturer agrees to $500 million penalty
Monday, May 13, 2013
WASHINGTON — A subsidiary of an Indian pharmaceutical company has agreed to pay $500 million fines and civil penalties for selling adulterated drugs and lying about tests to federal regulators, the Justice Department said Monday. ...
Subscribers must LOG-IN
to read this full story.
If you are a current print subscribers and would like access to our complete online edition CLICK HERE
For new online-only & print/online combo subscriptions CLICK HERE
Stories can also be purchased from our archives for $2.00 per article.
to search our archives.
CLICK HERE to login to dailygazette.com.